Protocolo de manejo del paciente con terapia de óxido nítrico

Resumo

Introduction and objectives: Right ventricle failure in the peri-operative period of patients who have undergone cardiac surgery is usually related to pulmonary hypertension (PHT) and is an independent risk factor of death in this surgery. Inhaled nitric oxide (NO) produces selective pulmonary vasodilation, hence it is the ideal drug for treating PHT, thus protecting and maintaining cardiac function. NO administration at intensive care units requires rigorous monitoring, correct assembly and close surveillance of the patient by the nursing staff. That is why we believe it is necessary to unify knowledge and action criteria in a protocol that serves as a guide for all professionals. Methodology: A bibliographic review was made on the most important databases (PubMed, CUIDEN, IBECS, etc.), books and documents published by various professional associations were reviewed and several practical guides and manuals from different commercial rms were examined. The NANDA II-NIC-NOC taxonomy was used for the development of the care plan. Results: A protocol was developed re€ecting the NO basic principles, its indications in cardiac surgery, dosing, monitoring, side effects and handling precautions. Later on, a standardized care plan was developed for the care of patients on this therapy. Discussion: NO therapy has involved an improvement in cardiac patient care, since the use thereof following surgery reduces post-operative morbidity. It is a role of the whole nursing staff to know its properties and adequate handling, thereby reducing the complications that might occur. Using nursing taxonomies has provided a useful resource in developing the care plan, and will make these patients follow-up easier